ClinicalTrials.gov
ClinicalTrials.gov Menu

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00593190
Recruitment Status : Unknown
Verified January 2008 by HaEmek Medical Center, Israel.
Recruitment status was:  Recruiting
First Posted : January 14, 2008
Last Update Posted : January 14, 2008
Sponsor:
Information provided by:
HaEmek Medical Center, Israel

Brief Summary:
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

Condition or disease Intervention/treatment Phase
Hydrops in Keratoconus Drug: Gas SF6 (Sulfur Hexafluoride) Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2008
Estimated Primary Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Edema
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1 Drug: Gas SF6 (Sulfur Hexafluoride)
ONCE



Primary Outcome Measures :
  1. Hydrops resulotion [ Time Frame: weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hydrops

Exclusion Criteria:

  • Age < 18 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00593190


Contacts
Contact: Boris Safianik, Dr 972-4-6494000

Locations
Israel
HaEmek Medical Center Recruiting
Afula, Israel
Principal Investigator: Boris Safianik, Dr         
Sponsors and Collaborators
HaEmek Medical Center, Israel

Responsible Party: Dr. Boris Safianik, Ha'Emek Medical Center
ClinicalTrials.gov Identifier: NCT00593190     History of Changes
Other Study ID Numbers: 0097-07-EMC
First Posted: January 14, 2008    Key Record Dates
Last Update Posted: January 14, 2008
Last Verified: January 2008

Additional relevant MeSH terms:
Keratoconus
Edema
Corneal Diseases
Eye Diseases
Signs and Symptoms